ACM
UTHR icon

AUA Capital Management’s United Therapeutics UTHR Stock Holding History

AUA Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-30
Closed -$8.34K – 319
2022
Q4 		$8.34K Hold
30
– – 0.01% 162
2022
Q3 		$6K Sell
30
-5
-14% -$1.12K ﹤0.01% 190
2022
Q2 		$8K Buy
35
+1
+3% +$203 ﹤0.01% 176
2022
Q1 		$6K Sell
34
-6
-15% -$1.14K ﹤0.01% 203
2021
Q4 		$9K Sell
40
-2
-5% -$393 0.01% 171
2021
Q3 		$8K Buy
42
+2
+5% +$394 0.01% 168
2021
Q2 		$7K Buy
40
+2
+5% +$381 ﹤0.01% 177
2021
Q1 		$6K Buy
38
+33
+660% +$5.5K ﹤0.01% 196
2020
Q4 		$1K Buy
+5
New +$656 ﹤0.01% 332

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

AUA Capital Management's UTHR Position: Q1 2023 in Review

AUA Capital Management sold out of United Therapeutics (UTHR) in Q1 2023, closing a stake of 30 shares — an estimated $8.34K sold.

AUA Capital Management first reported a position in UTHR in Q4 2020 and held it in 9 quarters. The position peaked at $9K in Q4 2021. 505 funds tracked by Wall St. Rank hold UTHR as of Q1 2023.

  • AUA Capital Management reported no remaining United Therapeutics position as of Q1 2023 after selling out during the quarter.
  • AUA Capital Management sold 30 United Therapeutics shares in Q1 2023, an estimated $8.34K.
  • AUA Capital Management first reported a position in United Therapeutics in Q4 2020 and held it in 9 quarters.
  • AUA Capital Management's United Therapeutics position peaked at $9K in Q4 2021.
  • 505 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2023.

Based on AUA Capital Management's 13F filing for Q1 2023, filed 20 Apr 2023.